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How aging impacts axon regeneration after CNS
injury is not known. We assessed the impact of age
on axon regeneration induced by Pten deletion in
corticospinal and rubrospinal neurons, two neuronal
populations with distinct innate regenerative abili-
ties. As in young mice, Pten deletion in older mice
remains effective in preventing axotomy-induced
decline in neuron-intrinsic growth state, as assessed
by mTOR activity, neuronal soma size, and axonal
growth proximal to a spinal cord injury. However,
axonal regeneration distal to injury is greatly dimin-
ished, accompanied by increased expression of as-
troglial and inflammatory markers at the injury site.
Thus, themammalian CNS undergoes an age-depen-
dent decline in axon regeneration, as revealed when
neuron-intrinsic growth state is elevated. These re-
sults have important implications for developing
strategies to promote axonal repair after CNS injuries
or diseases, which increasingly affect middle-aged
to aging populations.INTRODUCTION
Spinal cord injury is increasingly inflicted in older populations
(DeVivo and Chen, 2011; Singh et al., 2014). The average age
of incidence for spinal cord injury has risen substantially in recent
years, from 29 in the 1970s to 42 since 2010 in the United
States (National Spinal Cord Injury Statistical Center) due to an
increasingly active older population. This changing demographic
calls for a critical need to better understand how aging impacts
recovery and repair after spinal cord injury. Despite the central
importance of axon regeneration in spinal cord repair (Bradke
and Marı´n, 2014; Silver et al., 2015), how aging impacts CNS
axon regeneration is not well understood, largely because CNS
axons, even in young adult mammals, naturally have a very238 Cell Reports 15, 238–246, April 12, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://limited ability to regenerate after injury. The recent discovery of
neuron-intrinsic factors whose manipulation reproducibly pro-
motes axon regeneration in the CNS (Lu et al., 2014) has made
it possible to address this question.
To assess the impact of increased age on CNS axon regener-
ation, we asked whether genetic Pten deletion, a molecular
manipulation that promotes significant CNS axon regeneration
in young adult mammals (Liu et al., 2010; Park et al., 2008), re-
mains effective in older animals (up to 12–18 months old).
PTEN is a negative regulator of the mTOR (mammalian target
of rapamycin) signaling pathway (Ma and Blenis, 2009). Neuronal
mTOR activity undergoes development-dependent decline and
is further downregulated after axonal injury in the adult CNS
(Liu et al., 2010; Park et al., 2008). Genetic Pten deletion in young
animals prevents axotomy-induced reduction of mTOR activity
and promotes the regeneration of both retinal ganglion and cor-
ticospinal tract (CST) axons after CNS injury (Liu et al., 2010; Park
et al., 2008).
Here, we examined the effect of age on axon regeneration in
the mammalian CNS using both the CST and the rubrospinal
tract (RST) as the model systems. Our data indicate that aging
may dissociate neuron-intrinsic growth state and axon regener-
ation in Pten-deleted mice, neuronal properties previously
considered inseparable. Specifically, while Pten deletion in mid-
dle-aged to aging mice continues to promote a neuron-intrinsic
growth state as assessed by mTOR activity, neuronal soma
size, and axonal growth proximal to a spinal cord injury, it loses
effectiveness in promoting axon regeneration distal to the injury
as compared with young mice. These results reveal an age-
dependent decline in CNS axon regeneration and implicate
changes in neuron-extrinsic influences in this age-dependent
decline.RESULTS
TheDiminishing Effect ofPtenDeletion onCorticospinal
Axon Regeneration with Increasing Age
We previously observed significant CST axon regeneration
after a dorsal hemisection (DH) spinal cord injury in youngcreativecommons.org/licenses/by-nc-nd/4.0/).
Pten-deleted mice (Liu et al., 2010). In that study, Pten deletion
was initiated at postnatal day 1 (P1) by unilateral cortical AAV-
Cre injection into the sensorimotor cortex of homozygous Pten
conditional mutant (Ptenf/f) mice, and the injury was performed
at 6 weeks of age. To systematically examine the impact of
age on the CST regeneration-promoting effect of Pten deletion,
we induced Pten deletion by AAV-Cre injection (along with
AAV-GFP controls) in P1, 4- to 6-week-old, 10-week-old, and
12- to 18-month-old PTENf/f mice. Four to six weeks later, we
performed a T8 dorsal hemisection injury, which severs virtually
all labeled CST axons (Lee et al., 2010; Liu et al., 2010; Zheng
et al., 2006). Axon tracer biotinylated dextran amine (BDA) was
injected into the sensorimotor cortex 4 weeks later, and the
mice were killed and analyzed for BDA-traced CST axons two
additional weeks later (thus, a survival period of 6 weeks after
injury).
After a penetrating injury in mice, a glial fibrillary acidic protein
(GFAP) sparse injury epicenter is surrounded by GFAP-dense
areas reflecting reactive astrogliosis immediately rostral and
caudal to the epicenter (Herrmann et al., 2010). Rostral to injury,
CST axons in control mice exhibited typical retraction (or
dieback) from the injury site for a few hundred micrometers (Fig-
ures 1A and 1A0), as quantified with axon density index (BDA
labeling density at defined distances normalized to that at
1.5 mm rostral to injury) (Figure 1F). As expected (Liu et al.,
2010), there was a significant increase in axon density immedi-
ately rostral to the injury site in mice when Pten deletion was initi-
ated at P1 (Figures 1B, 1B0, and 1F). That CST axons are
detected all the way to the very rostral edge of the lesion
epicenter is a hallmark of the effect of Pten deletion and has
been shown to result from enhanced CST axon regrowth and
not reduced axonal dieback in younger mice (Liu et al., 2010).
Interestingly, initiating Pten deletion at 4–6 weeks, 10 weeks,
or even 12–18 months of age led to similar increases of CST
axon density immediately rostral to the injury site, such that no
significant differences were observed among different age
groups (Figures 1B–1E0 and 1F). To rule out the possibility that
Pten deletion only in older mice alters axonal dieback early after
injury, we compared CST axon labeling rostral to injury between
12-month-old control and Pten-deleted mice that carry the
ROSA26-lsl-tdTomato genetic reporter (Madisen et al., 2010).
There was no significant difference in rostral CST axon label-
ing, as assessed with either BDA or the genetically encoded
tdTomato tracer, at 10 days after a dorsal hemisection spinal
cord injury between old control and age-matched Pten deleted
mice (Figures S1A–S1C), indicating that Pten deletion does not
alter CST axon dieback in old mice. Consequently, the increased
CST labeling proximal to the injury site at the later time point
most likely reflected axonal growth, but not less axonal dieback,
in Pten-deleted aging mice. Together, these data indicate that
Pten deletion promotes rostral CST axon growth toward a spinal
cord injury site independently of age.
In stark contrast, CST axon regeneration caudal to the injury
site in Pten-deleted mice varied greatly with age. As expected
(Liu et al., 2010), initiating Pten deletion in P1 mice led to signif-
icant CST regeneration caudal to injury in young adult mice
as compared to controls (Figures 1B, 1B0, 1G, and 1H). At
increasing ages of initiating Pten deletion, from P1, 4–6 weeks,10 weeks, to 12–18 months, CST regeneration caudal to injury
(assessed in mice 10–12 weeks older) was increasingly dimin-
ished, as quantified by the axon number index (the number of
axons within specific distance intervals caudal to injury, normal-
ized against the total number of axons labeled in the medulla)
(Figure 1B–1E0 and 1G). The 4- to 6-week deletion group had
a slight decrease in axon regeneration caudal to injury as
compared with the P1 group that did not reach statistical signif-
icance (two-way ANOVA). The 10-week group had significantly
less axon regeneration at 50, 150, and 250 mm caudal to injury
as compared with the P1 group. This decrease in CST regener-
ation was even more pronounced in the 12- to 18-month group,
in whichPten deletion led to little, if any, regeneration. 44%of the
P1 deletion group, 21% of the 4- to 6-week group, and 0% of the
10-week or 12-18 month groups presented any axons at 750 mm
or more distal to injury (i.e., 750 mm is approximately half of
maximal regeneration distance in the P1 group). Plotting the cu-
mulative axon number index past this 0.75-mm mark confirmed
a clear trend for diminishing CST regeneration at increasing ages
(Figure 1H). Thus, while Pten deletion in older mice remains
effective in eliciting CST axon growth rostral to a spinal cord
injury, its effect on promotingCST regeneration beyond the injury
site is increasingly diminished with increasing ages.
The Diminishing Effect of Pten Deletion on Rubrospinal
Axon Regeneration with Increasing Age
To determinewhether this age-dependent decline in axon regen-
eration is unique to the CST or can be extended to another
axonal tract, we examined the regeneration of another descend-
ing motor tract, the rubrospinal tract (RST). The RST possesses
a higher innate regenerative ability than the CST (Blesch and
Tuszynski, 2009). We performed targeted injections of AAV-
Cre-GFP (or AAV-GFP as control) into the vicinity of the right
red nucleus of 4-week-old or 7- to 8-month-old homozygous
Pten conditional mutant (Ptenf/f) mice (Groszer et al., 2001).
Four weeks later, mice underwent a C4 dorsolateral funiculus
crush (DLF) injury to unilaterally and completely axotomize the
RST similarly to as previously described (Hilton et al., 2013), fol-
lowed by an 8-week survival period. Immunoreactivity to GFP
was used as the axonal tracer, with the advantage over BDA
that GFP-labeled rubrospinal neurons had presumably sus-
tained Pten deletion.
In control AAV-GFP-injected control mice, the injured rubro-
spinal tract underwent characteristic dieback from the lesion
site (Figures 2A–2B0 0). In contrast, when Pten deletion was initi-
ated at 4 weeks of age, the main RST bundle extended into the
lesion epicenter (Figures 2C–2C0 0 and 2E), and the axon number
index at the injury center was significantly higher than controls
(all normalized to 1.5 mm rostral to lesion) (Figure 2E). Whereas
in control mice there was no RST axon detected at or beyond
1.0 mm caudal to injury, in Pten-deleted mice, RST axons were
found to extend up to 1.5 mm caudally to injury (Figures 2C–
2C0 0 and 2F). Injured RST axons took a route to grow laterally
toward the injury site in the gray matter following Pten deletion
(as seen on the horizontal sections in Figures 2C–2C0 0). These
data demonstrate that, when initiated at a young age (4 weeks),
Pten deletion can efficiently promote RST regeneration after
injury.Cell Reports 15, 238–246, April 12, 2016 239
Figure 1. The Effect of Age on CST Regeneration in Pten-Deleted Mice after T8 Dorsal Hemisection Spinal Cord Injury
(A–E0) Representative images of spinal cord sagittal sections showing BDA-labeled CST axons around the injury site (marked with an arrow) from control (Ctrl) or
Pten-deletedmice (KO). P1 (postnatal day 1), 4–6 weeks (4-6w) , 10 weeks (10w), and 12–18 months (12-18m) refer to the age at which Pten deletion was initiated
by AAV-Cre injection into the right sensorimotor cortex of PTENf/fmice. AAV-GFP injection served as the control. Scale bars, 200 mm. Caudal is always to the right
in this and all other spinal cord images.
(F) Quantification of rostral CST axon labeling, including controls for the P1, 4–6 week, and 12-month groups.
(G) Quantification of caudal CST axon regeneration. The data for controls were zeros or close to zeros with essentially no error bars. Two-way ANOVA
followed by Bonferroni’s post hoc test: *p < 0.05, **p < 0.01, and ***p < 0.001. Green *, P1 and 4-6w versus 12-18 m; green @, P1 versus 12-18m; blue *, P1
and 4-6w versus 10w; blue @, P1 versus 10w. N = 14 (P1 Ctrl); 8 (4- to 6-week Ctrl); 5 (12- to 18-month Ctrl); 11 (P1 KO); 14 (4- to 6-week KO); 4 (10-week KO);
12 (12- to 18-month KO).
(H) Cumulative axon number index observed past 0.75 mm caudal to injury. See also Figure S1.When Pten deletion was initiated at 7–8 months of age, a sub-
stantial decrease in RST regeneration caudal to the injury site
was observed as compared with the 4-week group (Figures
2D–2D0 0, 2F, and 2H). At 0.5 mm caudal to injury, the axon num-
ber index in the 7- to 8-month deletion group was not signifi-240 Cell Reports 15, 238–246, April 12, 2016cantly different from (non Pten-deleted) control mice but was
significantly lower than that of the 4-week group (Figure 2F).
This number dropped to zero, with no GFP-positive axons
observed at or beyond 1 mm caudal to injury (Figure 2H). Never-
theless, Pten deletion resulted in a significantly higher axon
Figure 2. The Effect of Age on RST Regeneration in Pten-Deleted Mice after C4 Dorsolateral Funiculus Crush Spinal Cord Injury
(A–D0 0) Representative images of spinal cord horizontal sections showing GFP-labeled RST axons around the injury site (arrow) from control (Ctrl) or Pten-deleted
mice (KO). 4 weeks (4w) and 7–8 months (7-8m) refer to the age at which Pten deletion was initiated by AAV-Cre-GFP injection into the right red nucleus of Ptenf/f
mice. (A0), (B0), (C0), and (D0) are 160 mm ventral to (A), (B), (C), and (D), respectively, while (A0 0), (B0 0), (C0 0 ), and (D0 0) are 320 mm ventral to (A), (B), (C), and (D),
respectively. AAV-GFP injection served as the control. Here, we include a 7-8m KO animal with relatively higher GFP labeling (D) to exemplify the lack of caudal
axon growth in aged Pten KO animals. Scale bar, 200 mm.
(E) Quantification of RST axon labeling rostral to and at (0.0 mm) the injury site. Two-way ANOVA followed by Bonferroni’s post hoc test: *p < 0.05; black *, 4w and
7-8m KO versus 4w and 7-8m WT.
(F) Quantification of caudal RST axon regeneration. Two-way ANOVA followed by Bonferroni’s post hoc test: **p < 0.01; red **, 4w KO versus 7-8m KO, 4w WT,
and 7-8m WT.
(G) Axon number index observed at the middle of the injury site. This is the same information shown at 0.0 mm from the injury site in (E).
(H) Cumulative axon number index observed atR1 mm caudal to the injury site. N = 8 (4w WT), 8 (7-8m WT), 8 (4w KO), and 8 (7-8m KO).
See also Figure S1.number index irrespective of age when compared with the con-
trol groups at 0.5 mm rostral to injury and at the injury epicenter
(Figures 2E and 2G). Just as for the CST, Pten deletion in old
mice did not impact RST axonal dieback, assessed 7 days after
injury, when compared with age-matched control wild-type (WT)
mice (Figures S1D–S1F). Together, these data indicate that as
similar to the CST, Pten deletion in older mice remains effective
in eliciting rostral RST axon growth toward and into the spinal
cord injury site but has a substantially diminished effect on pro-
moting RST regeneration beyond the injury site.Pten Deletion Rescues Axotomy-Induced mTOR
Downregulation and Cell Atrophy in Both Rubrospinal
and Corticospinal Neurons Regardless of Age
Previous studies indicate that corticospinal and rubrospinal neu-
rons undergo cell atrophy (as indicated by soma size shrinkage)
following axonal injury (Carter et al., 2008; Kobayashi et al., 1997)
and that Pten deletion leads to enlarged soma size in retinal gan-
glion neurons (Park et al., 2008). Aging may impact the regener-
ation-promoting effect of targeting Pten in two different ways.
First, Pten deletion in aging mice may not be as effective inCell Reports 15, 238–246, April 12, 2016 241
Figure 3. Pten Deletion Prevents Axotomy-Induced Reduction of mTOR Signaling and Soma Size in Rubrospinal and Corticospinal Neurons
Independently of Age
(A–C) Representative transverse sections through magnocellular red nucleus showing NeuN+ rubrospinal neurons stained for p-S6 and GFP in young uninjured
control (A), young injured control (B), and old injured Pten KO (C) mice.
(D–F) Representative coronal sections of layer 5 sensorimotor cortex showing cortical neurons stained for p-S6. In Pten KO mice, the AAV-Cre-injected side
would have Pten deletion.
(G and H) Quantification of p-S6 immunoreactivity (G) and soma size (H) for rubral and layer 5 cortical neurons. For rubrospinal neurons, WT (GFP negative), and
KO (GFP positive) values represent intermingled Pten non-deleted and deleted neurons, respectively, within the same injected and injured red nucleus based on
NeuN staining. Scale bars, 25 mm. One-way ANOVA, Bonferroni’s post hoc test: *p < 0.05.
See also Figures S2 and S3.rescuing axotomy-induced downregulation ofmTOR activity and
associated cell atrophy. Second, Pten deletion may still rescue
axotomy-induced mTOR downregulation and cell atrophy in
aging mice, but other factors intrinsic or extrinsic to neurons
contribute to regeneration failure. To distinguish these two pos-
sibilities, we analyzed the effect of different ages on the ability of
Pten deletion to rescue axotomy-inducedmTORdownregulation
and cell atrophy.
The level of p-S6 (phospho-S6 ribosomal protein), an indicator
of mTOR activity, is relatively high in the red nuclei compared to
the rest of the midbrain in uninjured adult mice (Figures 3A and
S2A–S2C), consistent with the purportedly higher innate growth
ability of RST neurons. In control AAV-GFP-injected mice, p-S6
levels were significantly reduced in axotomized rubrospinal neu-
rons as compared with uninjured contralateral neurons (Figures
3B and 3G). This reduction occurred to a similar level in both
the 4-week group and the 7- to 8-month group, regardless of
GFP labeling (Figures S2D and S2E). However, in AAV-Cre-
GFP-injected, Pten-deletedmice, GFP-positive rubrospinal neu-
rons did not undergo p-S6 downregulation regardless of age
(Figures 3C, 3G, S2D, and S2E). In contrast, GFP-negative rubro-
spinal neurons in the same red nuclei, which presumably had not
undergone Pten deletion and were thus WT, exhibited a similar
level of p-S6 downregulation as in injured, AAV-GFP-injected
controls (Figures 3G and S2E).
In control AAV-GFP-injected mice, massive atrophy of rubro-
spinal neurons was observed regardless of GFP labeling (Figures
3B, 3H, and S2F–S2H), as indicated by a reduction in the average
cell surface area of NeuN-positive cells in the red nucleus as
compared to that of contralateral uninjured neurons (p < 0.05;242 Cell Reports 15, 238–246, April 12, 2016Figures 3H and S2F). This occurred regardless of age as there
was not a significant difference between the 4-week AAV-GFP-
injected group and the 7- to 8-month AAV-GFP-injected group
(Figures 3H and S2F–S2H). In contrast, Pten deletion completely
prevented rubrospinal cell body atrophy regardless of age (Fig-
ures 3H, S2F, S2G, and S2I).
Similarly, Pten deletion in the corticospinal neurons prevented
axotomy-induced p-S6 downregulation and associated cell atro-
phy (as assessed with soma area) independently of age (Figures
3D–3H and S3). Thus, aging does not appear to influence the
extent of mTOR activation induced by Pten deletion, at least as
assessed with p-S6 immunoreactivity and neuronal soma size.
Together, these data indicate that despite the greatly diminished
regeneration, Pten deletion remains effective in preventing
axotomy-induced downregulation of mTOR activity and associ-
ated cell atrophy in both rubrospinal and corticospinal neurons at
increased ages.
Increased Expression of Astroglial and Inflammatory
Markers at the Injury Site in Older Animals
Because Pten deletion promoted mTOR signaling and axon
growth rostral to injury irrespective of age in both the rubrospinal
and corticospinal systems, we hypothesized that differences in
environmental influences at and around the lesion site could be
responsible for the age-dependent decline in axon regeneration
beyond the injury site. To provide initial support for this hy-
pothesis, we compared the expression of several well-known
markers associated with glia-derived growth inhibition in young
and older mice by immunohistochemistry 6–8 weeks after
injury such as the astroglial marker GFAP, chondroitin sulfate
Figure 4. Aging Is Associated with Increased Expression of Astroglial and Inflammatory Markers around the Spinal Cord Injury Site
(A–D) Representative images and quantification (normalized to 1.5 mm rostral) of GFAP, CS-56, and Nogo-A immunoreactivity 6 weeks after dorsal hemisection
(DH) injury in mice of different ages.
(E–G) Representative images and quantification (normalized to the contralateral side) of GFAP and CS-56 immunoreactivity 8 weeks after dorsolateral funiculus
(DLF) crush injury in mice of different ages.
(H–J) Immunoreactivity and cell counts with microglia and macrophage marker CD68 after dorsal hemisection injury in mice of different ages.
Scale bars represent 200 mm (A–B0, E–F0, H, and I) or 20 mm (A1–B4, E1–F4, and H0-I0 0). Student’s t test: *p < 0.05. See also Figure S4.proteoglycans (CS-56), and the myelin-associated inhibitor
Nogo-A (Anderson et al., 2014; Cregg et al., 2014; Geoffroy
et al., 2015; Geoffroy and Zheng, 2014).
There was significantly increased GFAP upregulation around
the injury site at 6 weeks after dorsal hemisection injury in the
12- to 18-month deletion group as compared with the 4- to
6-week group in the CST regeneration study (Figures 4A–4C).
We assessed whether this increase in GFAP was a result of
increased astrocyte numbers in the vicinity of the lesion site by
triple staining for SOX9, GFAP, and Aldh1L1 (Cahoy et al.,2008; Pompolo and Harley, 2001; Zhang et al., 2014) and count-
ing the number of SOX9+ cells, which exhibit 98%–99%
co-labeling with the astrocyte markers GFAP or Aldh1L1. The
number of SOX9+ cells in the vicinity of the lesion site was not
different between young and aged mice (Figure S4N; images
not shown here, but see below), suggesting that increased
reaction of individual astrocytes, and not increased astrocyte
proliferation, underlies the age-associated increase in GFAP up-
regulation. Analyses of two additional time points, 7 and 21 days
after injury, suggested a more sustained GFAP upregulation inCell Reports 15, 238–246, April 12, 2016 243
older mice despite similar levels of upregulation early after injury
(Figure S4A). However, we did not detect significant differences
between young and old mice in CS-56 or Nogo-A upregulation at
the same three time points after dorsal hemisection injury (Fig-
ures 4A–4B0, 4D, S4B, and S4C). Similarly, antibodies that recog-
nize themore inhibitory moiety of CSPGs, chondrointin-4-sulfate
(C4S; also known as CS-A) (Lin et al., 2011; Wang et al., 2008) or
neurocan, did not detect overt differences in their upregulation
after injury between the age groups (Figures S4D–S4K). Simi-
larly, increasedGFAP, but not CS-56, upregulation in close prox-
imity to the injury site was observed in the older mice (7- to
8-month deletion group) as compared with the young mice
(4-week deletion group) after dorsolateral funiculus crush in the
RST regeneration study (Figures 4E–4G). As for the CST regen-
eration study, no difference in the number of SOX9+ astrocytes
was observed between the different age groups (Figures S4L–
S4N). Future studies are required to fully characterize the astro-
glial response in aging mice.
In addition to glia-derived factors, another aspect of neuron-
extrinsic influences that could impact axon regeneration is the
inflammatory response after spinal cord injury (Benowitz and Po-
povich, 2011). Indeed, immunoreactivity for CD68, a microglia/
macrophages marker, exhibited a more pronounced upregula-
tion around the injury site 6 weeks after dorsal hemisection in
the 12- to 18-month deletion group when compared with the
4- to 6-week group, which was paralleled with a significant in-
crease of CD68-positive cell number in the older mice (Figures
4H–4J). Together, these results indicate that both astroglial
and macrophage responses to injury are higher or more sus-
tained in older mice than in young mice, offering possible ex-
planations for the diminished axon regeneration through and
beyond the injury site in aging mice.
DISCUSSION
Here, we studied the impact of age and aging on axon regener-
ation in the adult mammalian CNS. Our results reveal an age-
dependent decline in CNS axon regeneration in Pten-deleted
mice. However, Pten deletion in older animals remains effective
in elevating neuron-intrinsic growth state as assessed by mTOR
activity, neuronal soma size, and axonal growth proximal to the
injury site. These observations support the hypothesis that
PTEN inhibits neuronal growth state independently of age in
the mammalian CNS. This dichotomy in the effects of Pten dele-
tion on neuronal growth state versus axon regeneration in
middle-aged to aging mice implicates neuron-extrinsic influ-
ences at and around the injury site as at least one underlying
mechanism for this age-dependent decline in regeneration.
An important conclusion from this study is that at increased
age, the regeneration-promoting effect of Pten deletion is greatly
diminished in both the corticospinal and rubrospinal tracts.
Although CST and RST differ significantly in their innate regener-
ative abilities, the models employed here to study their regener-
ation differ significantly (thoracic dorsal hemisection versus
cervical dorsolateral funiculus crush), and the two axonal tracts
were studied in two different laboratories (the CST in B.Z.’s lab
and the RST in W.T.’s lab), strikingly similar results were found,
indicating the general applicability of our findings. The survival244 Cell Reports 15, 238–246, April 12, 2016period after injury in our experiments was 6 weeks for the CST
and 8 weeks for the RST. It is possible that aging simply slows
the speed of axon regeneration due to a more challenging envi-
ronment, and if so, significant regeneration caudal to injury re-
mains possible in aging mice with a much longer survival period
than the ones tested here (Du et al., 2015). However, the conclu-
sion that aging diminishes the regeneration-promoting effect of
Pten deletion in the CNS continues to hold.
Combined with the rescue of axotomy-induced mTOR down-
regulation and cell atrophy, the robust axon growth rostral to
injury provides strong evidence that Pten-deleted neurons,
even at an advanced age, possess a high level of axon growth
ability. Thus, instead of a lack of neuron-intrinsic growth poten-
tial (Jaerve et al., 2012), as we had originally anticipated,
our data implicate an increased level of negative environmental
influence at the injury site in aging mice as at least one under-
lying mechanism for regeneration failure. It should be noted
that a greater inhibitory effect might also be mediated by an
enhanced response to the inhibitory environment due to
changes in receptor compositions and concentrations at the
neuronal or axonal surface, which are neuron intrinsic in
nature. In addition, changes in other aspects of neuron-intrinsic
growth state in aging neurons could have escaped detection
with the limited measures in our study. It is entirely possible
that manipulating other neuron-intrinsic pathways in combina-
tion with Pten deletion may lead to significantly more regener-
ation despite any increased negative extrinsic influences in the
aging CNS.
Given that PTEN inhibits axon regeneration independently of
age in Caenorhabditis elegans (Byrne et al., 2014), the age inde-
pendence of PTEN’s inhibitory effect on neuron-intrinsic growth
state appears to be evolutionarily conserved, except that in the
aging mammalian CNS, additional inhibitory mechanisms at
the injury site may become more prevalent in determining the
outcome of regeneration. Consistent with our observation of
increased GFAP upregulation at the spinal cord injury site in
aging mice, previous studies associated aging with increased
GFAP expression in uninjured brain or increased GFAP upre-
gulation following brain injury and stroke (Badan et al., 2003;
O’Callaghan andMiller, 1991; Sandhir et al., 2008). Other studies
implicated altered microglia/macrophage response in reduced
recovery after CNS injury in agedmice (Fenn et al., 2014; Sandhir
et al., 2008), while we found increased upregulation of CD68, a
marker for activated microglia and macrophages, following spi-
nal cord injury in older mice when compared with young mice.
Thus, increased astroglial and inflammatory responses along
with fibrotic scarring (Hellal et al., 2011; Herrmann et al., 2010;
Soderblom et al., 2013) may underlie, at least partially, the dimin-
ished effect on axon regeneration across and beyond the injury
site in aging Pten-deleted mice. Future studies are required to
pinpoint this mechanism.
In comparison to the CNS, axons in the peripheral nervous
system (PNS) regenerate robustly. Nevertheless, a similar age-
associated decline in peripheral nerve regeneration exists (Verdu´
et al., 2000). Recent studies attributed this age-associated
decline in PNS regeneration to a slower clearance of nerve and
myelin debris by Schwann cells (Kang and Lichtman, 2013;
Painter et al., 2014). Therefore, in both the mammalian PNS
and CNS, neuron-extrinsic mechanisms appear to contribute
to an age-dependent decline in axon regeneration after injury.
As the older mice in our experiments ranged from 7–8 months
to 12–18 months of age, our results have relevance not only to
aging individuals but also to the middle-aged population in hu-
mans. This is especially important for therapeutic development,
because although current preclinical models focus on young
animals, the average age of incidence for spinal cord injury (as
reported in the United States) is now at a middle age. Taking
into consideration this age effect will be enormously important
for mechanistic, preclinical, and future clinical studies to pro-
mote CNS repair in injury or disease.
EXPERIMENTAL PROCEDURES
Experimental Animals
All procedures were approved by the Institutional Animals Care and Use Com-
mittee at University of California, San Diego or by the Animal Care Committee
of the University of British Columbia in accordance with the guidelines of the
Canadian Council for Animal Care. The Pten conditional allele (Ptenflox, or
Ptenf) was obtained from The Jackson Laboratory (B6.129S4-Ptentm1Hwu/J;
stock #006440) (Lesche et al., 2002). AAV-Cre or control virus AAV-GFP was
injected into the sensorimotor cortex of different age groups for the dorsal
hemisection experimental groups, and AAV-Cre-GFP or AAV-GFP control
was injected into the red nucleus for the dorsolateral funiculus crush groups
(see Supplemental Experimental Procedures for details).
Corticospinal Tract Axotomy
DH spinal cord injury was performed as described elsewhere (Lee et al., 2010;
Liu et al., 2010), with minor modifications. Spinal cord injuries were performed
6 weeks after AAV injections in P1 mice and 4 weeks after AAV injections in
mice of all other age groups. Surgeons were blind to the genotypes. After a
T8 laminectomy, the dura was punctured bilaterally with a 30G needle.
A pair of superfine iridectomy scissors was used to cut slightly over dorsal
half of the spinal cord at a depth of 0.8 mm. Amicro feather ophthalmic scalpel
was used to retrace the lesion and ensure its completeness. Themuscle layers
were sutured and the skin was secured with wound clips and Dermabond.
Rubrospinal Tract Axotomy
Four weeks following red nucleus AAV injection, mice underwent a DLF crush
at the level of the fourth cervical vertebra (C4) to unilaterally sever the rubrospi-
nal tract similarly to as previously described (Hilton et al., 2013). Briefly, a
midline incision was made over the cervical vertebrae, and a C4 left hemilami-
nectomy was performed. The dura mater overlying the gray matter was
pierced with a 26G needle, and fine-tipped Dumont #5 forceps with custom
tips 200 mm in width were inserted, with one prong inserted into the dorsal
horn gray matter to a depth of 1 mm and the other prong placed lateral to
the dorsolateral funiculus. The forceps were closed and held for 15 s to sever
the RST; the forceps were removed and inserted again in order to repeat this
crush once. The muscles and skin were then closed with sutures and mice
were permitted to recover in a heated incubator.
BDA Tracing of CST Axons
Two weeks before euthanasia (i.e., 4 weeks post-DH), mice received stereo-
taxic injection of BDA (10%, D1956; Invitrogen) to label CST axons by antero-
grade tracing. The same injection volumes and coordinates were used for BDA
as for adult AAV injections (see above). For details on tissue processing,
immunostaining, and quantification, please see Supplemental Experimental
Procedures.
Statistics
Statistical tests were performed using GraphPad Prism version 6.0. Statistical
significance was set at p < 0.05. Post hoc comparisons were carried out only
when a main effect showed statistical significance. CST and RST regeneration
datawere analyzed using a two-way ANOVA followed byBonferroni’s post hoctest. Cell body data were analyzed using a one-way ANOVA followed by
Bonferroni’s post hoc test. Two-tailed Student’s t tests were used for single
comparisons between young versus aged mice.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.03.028.
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